Stoke Therapeutics Inc Capital Reinvestment Ratio
Stoke Therapeutics Inc capital reinvestment ratio. Stoke Therapeutics Inc (STOK) has a Capital Reinvestment Ratio of 0.00x as of March 2025, meaning it reinvests 0% of its operating cash flow ($131.83 Million) in capital expenditures ($152.00K). See STOK free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Stoke Therapeutics Inc (2025–2025)
Capital reinvestment ratio of Stoke Therapeutics Inc from 2025 to 2025. This chart tracks Stoke Therapeutics Inc's Capital Reinvestment Ratio across 1 annual periods. See financial agility of Stoke Therapeutics Inc to measure the company's free cash flow as a share of total liabilities.
Stoke Therapeutics Inc Capital Reinvestment Ratio by Year (2025–2025)
Stoke Therapeutics Inc capital reinvestment ratio by year from 2025 to 2025. For the full cash flow conversion analysis, see how efficiently does Stoke Therapeutics Inc generate cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.01x | $45.59 Million | $670.00K | — |